The Administrative Core will provide an efficient coordination of the component projects and activities, monitor the progress in the research programs, and assist in the development of plans for the future of the Center. It will coordinate, provide logistic support, and maintain budgetary oversight of the overall CCNE organizational framework, including the scientific cores and the education and training program. An internal Executive Committee and an external Advisory Board will provide scientific guidance and administrative oversight of the Center. This Core will handle the administrative details of the Center's affiliations with NCIdesignated Cancer Centers, SPOREs, and other CCNEs. Administrative Core will include the "scientific" PI (Vladimir Torchilin, Director), "clinical" PI (Nahum Goldberg), Associate Director (Mansoor Amiji), Center Administrator (Boris Levchenko) and Assistant (Grants and Contracts Specialist;to be named) to provide a day-by-day management of the CCNE and arrange regular meeting of all key participants, exchange of new information and samples between participants. The Administrative Core will function in close connection with the Executive Committee (to be assembled if and when this proposal is funded) and Advisory Board (to be assembled if and when this proposal is funded). This Core will also be facilitating contacts between individual investigators of the CCNE and Core Facilities as well as providing a required assistance for preparing regular reports to the NIH.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA151881-04
Application #
8537857
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$95,396
Indirect Cost
Name
Northeastern University
Department
Type
DUNS #
001423631
City
Boston
State
MA
Country
United States
Zip Code
02115
Essex, S; Navarro, G; Sabhachandani, P et al. (2015) Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors. Gene Ther 22:257-66
Abouzeid, Abraham H; Patel, Niravkumar R; Torchilin, Vladimir P (2014) Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. Int J Pharm 464:178-84
Xu, Jing; Singh, Amit; Amiji, Mansoor M (2014) Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer 14:75
Perche, F; Biswas, S; Wang, T et al. (2014) Hypoxia-targeted siRNA delivery. Angew Chem Int Ed Engl 53:3362-6
Zhu, Lin; Perche, Federico; Wang, Tao et al. (2014) Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials 35:4213-22
Bedi, Deepa; Gillespie, James W; Petrenko, Valery A (2014) Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Eng Des Sel 27:235-43
Sarisozen, Can; Abouzeid, Abraham H; Torchilin, Vladimir P (2014) The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Eur J Pharm Biopharm 88:539-50
Torchilin, Vladimir P (2014) Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov 13:813-27
Kommagalla, Yadagiri; Cornea, Sinziana; Riehle, Robert et al. (2014) Optimization of the anti-cancer activity of phosphatidylinositol-3 kinase pathway inhibitor PITENIN-1: switching a thiourea with 1,2,3-triazole. Medchemcomm 5:1359-1363
Ganta, Srinivas; Singh, Amit; Patel, Niravkumar R et al. (2014) Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer. Pharm Res 31:2490-502

Showing the most recent 10 out of 38 publications